Two vulnerabilities in the n8n workflow automation platform could allow attackers to fully compromise affected instances, access sensitive data, and execute arbitrary code on the underlying host.

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Here's a phrase to describe someone who overreacts easily ...